Pitti Group Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$234K Buy
1,076
+5
+0.5% +$1.11K 0.19% 71
2025
Q4
$245K Buy
1,071
+46
+4% +$10.5K 0.2% 66
2025
Q3
$237K Buy
+1,025
New +$209K 0.2% 66
2025
Q2
Sell
-1,018
Closed -$213K 79
2025
Q1
$213K Buy
+1,018
New +$198K 0.22% 71

Other funds holding ABBV

Pitti Group Wealth Management's ABBV Position: Q1 2026 in Review

Pitti Group Wealth Management increased its AbbVie (ABBV) stake by 0.47% in Q1 2026, buying an estimated $1.11K and bringing the position to 1,076 shares worth $234K. The position accounts for 0.19% of the portfolio, ranked #71.

Pitti Group Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $245K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Pitti Group Wealth Management held 1,076 shares of AbbVie worth $234K as of Q1 2026.
  • Pitti Group Wealth Management bought 5 AbbVie shares in Q1 2026, an estimated $1.11K.
  • AbbVie made up 0.19% of Pitti Group Wealth Management's portfolio in Q1 2026, its #71 holding.
  • Pitti Group Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Pitti Group Wealth Management's AbbVie position peaked at $245K in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pitti Group Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.